Brady Corporation (NYSE: BRC) — FY2014 Form 10-K
Reporting period: Fiscal year ended July 31, 2014; the filing also reports fourth-quarter results. Brady manufactures identification solutions, specialty materials, and workplace safety products. Financial amounts below are in U.S. dollars.
Financial performance and liquidity
| Metric | FY2014 | FY2013 |
|---|---|---|
| Net sales from continuing operations | $1,225.0 million | $1,157.8 million |
| Gross margin | $609.6 million; 49.8% of sales | $609.3 million; 52.6% of sales |
| Operating income (loss) | ($41.2) million | ($82.6) million |
| Continuing operations net income (loss) | ($48.1) million | ($138.3) million |
| Net income (loss), including discontinued operations | ($46.0) million | ($154.5) million |
| Operating cash flow | $93.4 million | $143.5 million |
| Capital expenditures | $43.4 million | $35.7 million |
| Cash and cash equivalents at year-end | $81.8 million | $91.1 million |
- Revenue rose 5.8%, comprising 0.2% organic growth, 5.7% acquisition contribution (primarily PDC), and a 0.1% currency headwind.
- FY2014 included $148.6 million in non-cash impairment charges, mainly for PeopleID, and $15.0 million in restructuring charges. Excluding these items, Brady reported operating income of $122.4 million, versus $147.9 million in FY2013; this is the company’s stated adjusted comparison, not GAAP operating income.
- Gross margin fell 2.8 percentage points, reflecting WPS sales and pricing pressures, facility consolidation costs, and IDS product mix, including a full year of lower-margin PDC sales.
- Total debt was approximately $263.2 million, including notes payable and long-term obligations. The company reported leverage of 1.7x under its debt-agreement definition and an 11.5x interest-coverage ratio; it was in compliance with covenants at year-end. The revolving credit facility had approximately $254.4 million available, and the China credit line had $4.8 million available.
- Dividends paid were $40.5 million and share repurchases were $30.6 million. The Class A annual dividend was subsequently increased from $0.78 to $0.80 per share.
Material changes and segment performance
- Identification Solutions (IDS): Sales increased 11.6% to $825.1 million, including 2.9% organic growth and 8.9% acquisition growth. Segment profit increased 1.0% to $176.1 million, but segment margin declined to 21.3% from 23.6%.
- Workplace Safety (WPS): Sales declined 4.5% to $399.9 million, including a 4.6% organic decline. Segment profit fell 30.5% to $66.2 million and segment margin declined to 16.6% from 22.7%. The organic sales trend improved during the year, with 0.9% positive growth in Q4.
- The Q4 reported operating loss was $116.0 million, including the year’s $148.6 million impairment charge. Q4 continuing-operations net loss was $97.0 million; Q4 sales were $316.7 million.
- The company sold the European and certain Asian Die-Cut operations in May 2014 for approximately $54.2 million. The China phase closed August 1, 2014, for approximately $7 million. Die-Cut results are presented as discontinued operations; FY2014 discontinued-operations earnings were $2.2 million.
- PDC, acquired in December 2012 for approximately $301.2 million, underperformed expected growth and sales synergies. Brady recorded $100.4 million of goodwill impairment and $48.2 million of intangible-asset impairment primarily in PeopleID.
Outlook, commentary, and risks
- The filing provides no specific company-wide revenue or earnings guidance. Management expected facility consolidation activity to continue into FY2015, with approximately $15 million of additional restructuring charges, and cited expected annual pre-tax savings of approximately $10 million from the facility plan.
- Management said WPS’ sales decline moderated through FY2014 and the segment returned to positive organic growth in Q4, attributing improvement to more catalog mailings, improved e-commerce execution, and pricing. Brady also described increased IDS investment, proprietary product development, and healthcare strategy changes focused on accounts, new products, and the full continuum of care.
- Key risks include execution of the healthcare and WPS strategies; persistent competition and price transparency online; economic weakness, notably in Brazil; facility-consolidation execution and customer-service disruption; foreign-exchange exposure; acquisition integration and further impairment risk; and potential tax costs if additional foreign cash is repatriated. Approximately 87.9% of cash was held outside the U.S.
- Brady reported no material pending litigation and no material off-balance-sheet arrangements. Deloitte issued an unqualified opinion on the financial statements and internal controls; management also concluded disclosure controls and internal control over financial reporting were effective.
- Leadership changed after year-end: J. Michael Nauman became CEO effective August 4, 2014; Thomas J. Felmer was appointed Workplace Safety president and Aaron J. Pearce CFO in September 2014.
Important facts for investors to verify
- Whether IDS organic growth can continue and whether the revised PDC/PeopleID strategy can meet its revised sales and profitability expectations.
- Whether WPS can sustain its Q4 return to organic growth and recover segment profitability amid e-commerce competition and pricing pressure.
- Actual restructuring charges, facility-consolidation savings, and any effects on quality, delivery, or customer retention in FY2015.
- Cash generation and working-capital trends, including the FY2014 decline in operating cash flow, alongside capital spending, dividends, repurchases, and scheduled debt payments.
- Progress on the Die-Cut China closing and any remaining disposal, indemnity, or tax consequences; the filing reports the final phase closed after year-end.
- Goodwill and intangible-asset valuation assumptions, remaining impairment exposure, and covenant headroom if operating performance weakens.